Zervas Scientific Consulting (Mark Zervas, Ph.D.)
@zervsciconsult.bsky.social
Innovative biomedical science leader who has led efforts to identify drug targets and developed novel assays to reveal disease mechanisms and to assess whether drug targets ameliorate cellular pathology.
New Position Paper from Zervas Scientific Consulting (ZSC) describing basic biology, discovery/preclinical approaches, clinical trial & IP aspects of SSRIs, Psilocybin, and MDMA (link below). Please cite Zervas Scientific Consulting (ZSC) if you use the document.
www.dropbox.com/scl/fi/j8o1b...
www.dropbox.com/scl/fi/j8o1b...
February 6, 2026 at 9:20 PM
New Position Paper from Zervas Scientific Consulting (ZSC) describing basic biology, discovery/preclinical approaches, clinical trial & IP aspects of SSRIs, Psilocybin, and MDMA (link below). Please cite Zervas Scientific Consulting (ZSC) if you use the document.
www.dropbox.com/scl/fi/j8o1b...
www.dropbox.com/scl/fi/j8o1b...
Pleased to share the first position paper from ZSC (link below).
“The Utility of Organoids and Assembloids in CNS Drug Discovery” is freely available.
Please cite Zervas Scientific Consulting (ZSC) if you use the document.
www.dropbox.com/scl/fi/ekjga...
“The Utility of Organoids and Assembloids in CNS Drug Discovery” is freely available.
Please cite Zervas Scientific Consulting (ZSC) if you use the document.
www.dropbox.com/scl/fi/ekjga...
November 12, 2025 at 2:30 PM
Pleased to share the first position paper from ZSC (link below).
“The Utility of Organoids and Assembloids in CNS Drug Discovery” is freely available.
Please cite Zervas Scientific Consulting (ZSC) if you use the document.
www.dropbox.com/scl/fi/ekjga...
“The Utility of Organoids and Assembloids in CNS Drug Discovery” is freely available.
Please cite Zervas Scientific Consulting (ZSC) if you use the document.
www.dropbox.com/scl/fi/ekjga...